The purpose of this study is to determine if flexibly-dosed ziprasidone is safe and
effective for the treatment of children and adolescents (ages 10-17) with bipolar I disorder
(manic or mixed).
Minimum age: 10 Years.
Maximum age: 17 Years.
Gender(s): Both.
Pfizer Investigational Site, Scottsdale, Arizona 85251, United States
Pfizer Investigational Site, Orange, California 92868, United States
Pfizer Investigational Site, San Diego, California 92123, United States
Pfizer Investigational Site, Denver, Colorado 80218, United States
Pfizer Investigational Site, Altamonte Springs, Florida 32701, United States
Pfizer Investigational Site, Ft. Lauderdale, Florida 33301, United States
Pfizer Investigational Site, North Miami, Florida 33161, United States
Pfizer Investigational Site, Orange City, Florida 32763, United States
Pfizer Investigational Site, Tavares, Florida 32778, United States
Pfizer Investigational Site, Decatur, Georgia 30033, United States
Pfizer Investigational Site, Honolulu, Hawaii 96826, United States
Pfizer Investigational Site, Des Plaines, Illinois 60016, United States
Pfizer Investigational Site, Schaumburg, Illinois 60194, United States
Pfizer Investigational Site, Terre Haute, Indiana 47802, United States
Pfizer Investigational Site, Lexington, Kentucky 40509, United States
Pfizer Investigational Site, Owensboro, Kentucky 42301, United States
Pfizer Investigational Site, Baton Rouge, Louisiana 70809, United States
Pfizer Investigational Site, Shreveport, Louisiana 71103, United States
Pfizer Investigational Site, Pikesville, Maryland 21208, United States
Pfizer Investigational Site, Towson, Maryland 21204, United States
Pfizer Investigational Site, Towson, Maryland 21286, United States
Pfizer Investigational Site, Clinton Township, Michigan 48038, United States
Pfizer Investigational Site, Meridian, Mississippi 39301, United States
Pfizer Investigational Site, St. Louis, Missouri 63044-2588, United States
Pfizer Investigational Site, Lincoln, Nebraska 68510, United States
Pfizer Investigational Site, Omaha, Nebraska 68131, United States
Pfizer Investigational Site, Albuquerque, New Mexico 87102, United States
Pfizer Investigational Site, Buffalo, New York 14215, United States
Pfizer Investigational Site, Rochester, New York 14618, United States
Pfizer Investigational Site, Cincinnati, Ohio 45267-0559, United States
Pfizer Investigational Site, Cincinnati, Ohio 45229, United States
Pfizer Investigational Site, Cincinnati, Ohio 45224, United States
Pfizer Investigational Site, Cleveland, Ohio 44106-5080, United States
Pfizer Investigational Site, Columbus, Ohio 43210, United States
Pfizer Investigational Site, Oklahoma City, Oklahoma 73101, United States
Pfizer Investigational Site, Oklahoma City, Oklahoma 73107, United States
Pfizer Investigational Site, Oklahoma City, Oklahoma 73112, United States
Pfizer Investigational Site, Oklahoma City, Oklahoma 73116, United States
Pfizer Investigational Site, Tulsa, Oklahoma 74114, United States
Pfizer Investigational Site, Charleston, South Carolina 29405, United States
Pfizer Investigational Site, Arlington, Texas 76011, United States
Pfizer Investigational Site, DeSoto, Texas 75115, United States
Pfizer Investigational Site, Fort Worth, Texas 76102, United States
Pfizer Investigational Site, Lake Jackson, Texas 77566, United States
Pfizer Investigational Site, Plano, Texas 75093, United States
Pfizer Investigational Site, San Antonio, Texas 78229, United States
Pfizer Investigational Site, Kirkland, Washington 98033, United States
Pfizer Investigational Site, Spokane, Washington 99204, United States
Pfizer Investigational Site, Milwaukee, Wisconsin 53226, United States
Pfizer Investigational Site, West Allis, Wisconsin 53227, United States